Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Leukemia
|
December 19, 2008
The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia
K Giannopoulos, D Mertens, A Bühler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
M Ghielmini, U Vitolo, E Kimby, et al.
Leukemia
|
March 17, 2016
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab
C L Freeman, M Dixon, R Houghton, et al.
Leukemia
|
May 5, 2015
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL
E Vasyutina, J M Boucas, J Bloehdorn, et al.
Leukemia
|
April 9, 2004
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
C-M Wendtner, M Ritgen, C D Schweighofer, et al.
Leukemia
|
April 18, 2006
Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression
M Bilban, D Heintel, T Scharl, et al.
Leukemia
|
April 29, 2005
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia
D Heintel, D Kienle, M Shehata, et al.
Leukemia
|
November 25, 2005
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia
S Skogsberg, G Tobin, A Kröber, et al.
Leukemia
|
February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
S Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia
|
August 15, 2017
Lamin B1 regulates somatic mutations and progression of B-cell malignancies
T Klymenko, J Bloehdorn, J Bahlo, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Leukemia
|
December 19, 2008
The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia
K Giannopoulos, D Mertens, A Bühler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
M Ghielmini, U Vitolo, E Kimby, et al.
Leukemia
|
March 17, 2016
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab
C L Freeman, M Dixon, R Houghton, et al.
Leukemia
|
May 5, 2015
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL
E Vasyutina, J M Boucas, J Bloehdorn, et al.
Leukemia
|
April 9, 2004
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
C-M Wendtner, M Ritgen, C D Schweighofer, et al.
Leukemia
|
April 18, 2006
Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression
M Bilban, D Heintel, T Scharl, et al.
Leukemia
|
April 29, 2005
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia
D Heintel, D Kienle, M Shehata, et al.
Leukemia
|
November 25, 2005
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia
S Skogsberg, G Tobin, A Kröber, et al.
Leukemia
|
February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
S Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia
|
August 15, 2017
Lamin B1 regulates somatic mutations and progression of B-cell malignancies
T Klymenko, J Bloehdorn, J Bahlo, et al.
Page
of 10